Apixaban dosing
US12295943B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Sep 22, 2023 |
| Grant date | May 13, 2025 |
| Priority date | — |
| Expiry date | Sep 22, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for administering a dosage of Apixaban to a patient for the treatment or prevention of thrombosis, the method comprising: administering a dosage of Apixaban to the patient, wherein the dosage of apixaban is determined by: receiving patient data relating to a patient, wherein the patient data includes a kidney function metric of the patient; and processing, using one or more processors, the patient data with a dosage calculator to determine the dosage of Apixaban for the patient, wherein the dosage calculator is derived from a plasma level prediction model that predicts Apixaban drug plasma levels, and the dosage calculator determines the dosage for the patient based in part on the kidney function metric of the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.